Summary
Latest filing:
Amit B. Shah is CFO of Oncotelic Therapeutics, Inc. (OTLC). 2 SEC Form 4 filings on record, most recently on 14 July 2026. Most recent open-market trade: bought $1K of OTLC on 22 June 2026. Lifetime open-market purchases: $1K.
Recent Transactions
1Every recent SEC Form 4 transaction Amit B. Shah has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Amit B. Shah files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Vuong Trieu - $37K of OTLC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Amit B. Shah?
Amit B. Shah is a corporate insider, tracked as CFO of Oncotelic Therapeutics, Inc. (OTLC). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Amit B. Shah submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Amit B. Shah been buying or selling stock?
Recorded transactions: 1 open-market purchase ($1K) and 0 open-market sales across all tracked filings.
Where can I see all of Amit B. Shah's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Amit B. Shah and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
